We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck said Tuesday its blockbuster cancer drug Keytruda (pembrolizumab) has received European Commission approval as a standalone therapy for two types of colorectal cancer. Read More
Gilead Sciences recently announced that it would no longer pursue FDA approval for Jyseleca and it downgraded a multibillion-dollar development pact with Galapagos. Read More
Cabenuva, the first long-acting injectable drug for HIV, has received FDA approval, providing the first-ever FDA-approved alternative to oral meds taken every day by those living with HIV. Read More
The CAR-T therapy uses the patient’s white blood cells as modified in a laboratory to attack cancer cells before being infused back into the patient. Read More
The approval was based on positive results from a phase 2 trial that showed Enhertu led to improvement in overall survival and response rate vs. chemotherapy. Read More